Pure Meets Effective.
We use only the highest-quality ingredients, sourced in the USA, and rigorously tested for purity.
RACETAMS & PEPTIDES
CHOLINE SOURCES
VITAMINS & AMINO ACIDS
RACETAMS & PEPTIDES
CHOLINE SOURCES
VITAMINS & AMINO ACIDS
Pramiracetam
There are 43 studies on Pramiracetam and counting.
Pramiracetam is also known as 1-Pyrrolidineacetamide.
Benefits
- Reduce Anxiety
- Verbal Memory
- Orientation
- Focus
- Mood
Pramiracetam is also known as 1-Pyrrolidineacetamide.
Purity
We are obsessed with quality control. All our ingredients are sourced from the USA and tested by independent third party labs to ensure purity. You can view the test results in our Certificate of Analysis.
Summary
Although its taste may some time to get used to, pramiracetam has shown to be a potent nootropic when it comes to improving memory. Pramiracetam was found not only to stimulate memory formation and improve recall, but was also found to improve subjects’ visual and verbal memory, while demonstrating a neuroprotective effect. In addition to strengthening memory, pramiracetam lengthened attention spans and improved focus in both adolescents and the elderly with cognitive impairment.
Selected Community Experience
“I didn’t know my brain could work like that. Incredibly focused. Picture that feeling when you can do nothing wrong and have complete trust in your abilities. Thoughts were clear, background noise muted. My memory was impressively quick. It’s a powerful nootropic, and combining it with some choline only enhanced the effects.” - Lawrence S.
References
Placebo-controlled study of pramiracetam in young males with memory and cognitive problems resulting from head injury and anoxia.
Pramiracetam effects on scopolamine-induced amnesia in healthy volunteers.
Experience in the application of pramistar, a new nootropic preparation, in the treatment of memory disorders in patients with cerebrovascular pathology
Application of nootropic agents in complex treatment of patients with concussion of the brain
Use of pramiracetam in elderly patients with mild cognitive impairment and arterial hypertension
